HighGravityData
Companies / Albemarle / Filing

Albemarle — Feb 12, 2025 release

Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000915913-25-000023
Open on SEC.gov ↗
Showing in the filing
Chengdu site
“into care and maintenance”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 35
Capital expenditures for FY2025
“$700 and $800 million”
Chengdu site for FY2025
“into care and maintenance”
Cost and productivity improvement target
“$300-400 million”
Energy Storage volume growth for FY2025
“0% to 10%”
Average lithium market price ($/kg LCE) (a) for FY2024
“$12-15”
Net sales for FY2024
“$4.9 - $5.2 billion”
Total Corporate net sales (YE 2024 observed … for FY2024
“$4.9 - $5.2 billion”
Total Corporate net sales (H1 2024 price ran… for FY2024
“$5.3 - $6.1 billion”
Total Corporate net sales (Q4 2023 average p… for FY2024
“$6.5 - $7.0 billion”
Net sales for Q4 FY2023
“$6.5 - $7.0 billion”
Adjusted EBITDA (b) for FY2024
“$0.8 - $1.0 billion”
Total Corporate adjusted EBITDA (YE 2024 obs… for FY2024
“$0.8 - $1.0 billion”
Total Corporate adjusted EBITDA (H1 2024 pri… for FY2024
“$1.2 - $1.8 billion”
Total Corporate adjusted EBITDA (Q4 2023 ave… for FY2024
“$2.5 - $2.7 billion”
Adjusted EBITDA (b) for Q4 FY2023
“$2.5 - $2.7 billion”
Energy Storage net sales (YE 2024 observed m… for FY2024
“$2.5 - $2.6 billion”
Energy Storage net sales (H1 2024 price rang… for FY2024
“$2.9 - $3.5 billion”
Energy Storage net sales (Q4 2023 average pr… for FY2024
“$4.2 - $4.5 billion”
Adjusted EBITDA for FY2024
“$0.6 - $0.7 billion”
Energy Storage adjusted EBITDA (YE 2024 obse… for FY2024
“$0.6 - $0.7 billion”
Energy Storage adjusted EBITDA (H1 2024 pric… for FY2024
“$1.0 - $1.5 billion”
Energy Storage adjusted EBITDA (Q4 2023 aver… for FY2024
“$2.2 - $2.4 billion”
Adjusted EBITDA for Q4 FY2023
“$2.2 - $2.4 billion”
Energy Storage equity in net income of uncon… for FY2024
“$0.2 - $0.3 billion”
Energy Storage equity in net income of uncon… for FY2024
“$0.3 - $0.5 billion”
Energy Storage equity in net income of uncon… for FY2024
“$0.6 - $0.7 billion”
Specialties net sales for FY2025
“$1.3 - $1.5 billion”
Specialties adjusted EBITDA for FY2025
“$210 - $280 million”
Ketjen net sales for FY2025
“$1.0 - $1.1 billion”
Ketjen adjusted EBITDA for FY2025
“$120 - $150 million”
Depreciation and amortization for FY2025
“$630 - $670 million”
Adjusted effective tax rate (a) for FY2025
“(40%) - 25%”
Corporate costs for FY2025
“$70 - $100 million”
Interest and financing expenses for FY2025
“$180 - $210 million”
Weighted-average common shares outstanding (… for FY2025
“118 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
“As we look ahead, we expect dynamic market conditions to persist but remain confident in our ability to deliver value to stakeholders by increasing our financial flexibility, strengthening our core capabilities and positioning Albemarle for future growth.” Broad Actions Executed and Underway to Maintain Long-Term Competitiveness In 2024 and continuing into 2025, Albemarle has rapidly adjusted to market realities with steps that enhance our resilience, including: • Optimizing conversion network: achieved record production in the fourth quarter at La Negra and Meishan lithium conversion plants; announcing today plans to place Chengdu site into care and maintenance by mid-2025 and to shift a portion of Qinzhou production from hydroxide to carbonate • Improving costs and efficiency: streamlined organizational structure; achieved at year-end over 50% run-rate relative to the $300-400 million cost and productivity improvement target • Reducing capital expenditures: proactively re-phased growth investments; reduced 2024 capex by over $450 million year-over-year and plan to significantly reduce further in 2025 • Enhancing financial flexibility: pursued multiple cash generation steps and proactively amended credit agreement to fortify balance sheet and navigate near-term dynamics 1 Fourth Quarter 2024 Results In millions, except per share amounts Q4 2024 Q4 2023 $ Change % Change Net sales $ 1,231.7  $ 2,356.2  $ (1,124.5) (47.7) % Net income (loss) attributable to Albemarle Corporation $ 75.3  $ (617.7) $ 693.0  (112.2) % Adjusted EBITDA (a)(b) $ 250.7  $ (134.9) $ 385.6  (285.8) % Diluted earnings (loss) per share attributable to common shareholders $ 0.29  $ (5.26) $ 5.55  (105.5) %    Non-operating pension and OPEB items (a) (0.07) (0.07)    Non-recurring and other unusual items (a) (1.31) 0.14  Adjusted loss earnings per share attributable to
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.